Novartis expands in radio-oncology again with $1.3bn Artios allianceIn its second licensing deal in the radio-oncology area in consecutive weeks, Novartis has agreed a $1.3 billion-plus Share XNovartis expands in radio-oncology again with $1.3bn Artios alliancehttps://pharmaphorum.com/news/novartis-expands-in-radio-oncology-again-with-1-3bn-artios-alliance/
Novartis builds radio-oncology pipeline with iTheranostics dealNovartis has added to its pipeline of radiopharmaceuticals once again, licensing a series of agents from iTheranostics that Share XNovartis builds radio-oncology pipeline with iTheranostics dealhttps://pharmaphorum.com/news/novartis-builds-radio-oncology-pipeline-with-itheranostics-deal/
SpectronRx Receives U.S. Nuclear Regulatory Commission Materials License for New FacilityLeading Radiopharma CDMO Opens Second Location Share XSpectronRx Receives U.S. Nuclear Regulatory Commission Materials License for New Facilityhttps://pharmaphorum.com/partner-content/spectronrx-receives-u-s-nuclear-regulatory-commission-materials-license-for-new-facility/